课题基金 / 基金详情

Type IV collagenase inhibitor as an angiogenic inhibitor

Type IV collagenase inhibitor as an angiogenic inhibitor
IV 型胶原酶抑制剂作为血管生成抑制剂
批准号:
04671425
负责人:
SHIMAMURA Mariko
金额:
$1.22万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

SHIMAMURA Mariko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Angiogenesis, neovascularization, is an essential phenomenon not only in normal physiological process, but also in some disease states such as chronic inflammation and tumor formation. Many reports have shown the importance of angiogenesis for the progressive growth of solid tumors and the shedding of metastatic tumors from the primary sites. So the inhibition of angiogenesis may cause the suppression of tumor growth. Angiogenesis occurs via a copmlex cascade of events including activation of endothelial cells by angiogenic factor(s), degradation of the basement membrane by enzymes, migration, proliferation of capillary endothelial cells and tube formation by capillary endothelial cells. A variety of proteases have been implicated in angiogenesis, and collagenase and plasminogen activator have been suggested to play the important roles in degradation of the basement membrane. However, the dominant enzyme in angiogenesis in vivo has not been elucidated clearly. The clarification of the … More key enzymes in angiogenesis and their specific inhibitors may lead to search for potent inhibitors of angiogenesis, and may also lead to the regulation of tumor growth and metastasis through the inhibition of angiogenesis.Previously, we examined the effects of low molecular weight protease inhibitors on the angiogenesis of CAM to clarify the key enzyme during angiogenesis in vivo and found actinonin as a angiogenic inhibitor. We also examined theinhibitory mechanism of actinonin on angiogenesis, using capillary endothelial cells, and suggested that actinonin inhibited angiogenesis through the inhibition of type IV collagenase and that this enzyme was adominant enzyme in angiogenesis.In this study, we attempted to examine the correlation between the ability of the inhibition of type IV collagenase and angiogenesis inhibition, using actinonin and its derivatives, to determine whether this enzyme activity was important to angiogenesis. Both activities were correlative. We also examined the antitumor activity of actinonin. Actinonin inhibited the tumor uptake to the host. These results indicated that 1) type IV collagenase was a dominant enzyme in angiogenesis, 2) inhibition of type IV collagenase led to the angiogenesis inhibition and 3) type IV collagenase Less
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Oikawa,T.: "Effect of 15-deoxyspergualin,a microbial angiogenesis inhibitor,on the biological activities of bovine vascular endothelial cells." Anti-cancer drugs. 3. 293-299 (1992)
Oikawa,T.:“15-脱氧精胍菌素(一种微生物血管生成抑制剂)对牛血管内皮细胞生物活性的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oikawa,T.: "Inhibition of angiogenesis by staurosporine,a potent protein kinase inhibitor." J.Antibiot.45. 1160 (1992)
Oikawa,T.:“十字孢菌素(一种有效的蛋白激酶抑制剂)抑制血管生成。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
11
    HUMULONE, A POTENT COX-2 INHIBITOR FROM BEER HOP, INHIBITS ANGIOGENESIS
    POTENT INHIBITION OF ANGIOGENESIS BY HYPOXIA-DEPENDENT NOVEL NITROIMIDAZOLE
    海外基金